Archives

My guess is that the value of software patents is on the decline, taking value as the net of the economic upside of the software patent less the cost of  patent development, application and enforcement. The dynamic is that the benefit from patent protection in the software industry is less than the cost of the …

There is a reason why GM is in trouble and Toyota has displaced GM in the number one automobile manufacturer. Here is a piece from a colleague and friend – Todd Walzer, Todd and I worked together at Intel Fab 8 in Jerusalem in the 80′s. Working at Intel Jerusalem in the 1980′s, we were …

I just saw this on the LinkedIn Global Pharma Connections group – I thought it was great… If you have a need for someone with years of experience with handling DEA issues, please don’t hesitate to contact me. It is not easy… More » By Carlos M. Aquino

One of the biggest challenges in global multi-center clinical trials (after enrollment of patients) is collaboration between multi-center clinical trial teams: CRAs, investigators, regulatory, marketing, manufacturing, market research, data managers, statisticians and site administrators. In a complex global environment, pharma do not have control of computer platforms that local sites use – yet there is …

How does your company mitigate the risk of data security threats? Is your company management adopting a policy of “It’s other peoples money”? In a recent thread on LinkedIn - Jody Keyser shared some quotes from David Vose’s book on risk, reliability and computerized risk modeling:  Risk Analysis a quantitative guide. The responses to correctly identified …

One of the famous canons in the Jewish Passover “seder” ritual is 4 questions from 4 sons – the son who is wise, the son who is wicked, the son who is innocent and the son who doesn’t know enough to ask. I sometimes have this feeling of Deja vu when considering data security technology …